WOODCLIFF LAKE, N.J., Nov. 22, 2010 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has entered into an exclusive supply and distribution agreement with ...
For 25 years, a handful of drug firms, like Rhône-Poulenc Rorer and Schering Plough, have dominated the asthma market. But in the past decade, a growing number of biotech and drug companies have ...
Two drugs used to treat asthma and allergies may offer a way to prevent a form of pneumonia that can kill up to 40 percent of people who contract it, researchers at the University of Virginia School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results